α,N,N-TMT
From Wikipedia, the free encyclopedia
 |
|
|
α,N,N-TMT
|
|
| Systematic (IUPAC) name | |
| (2-(1H-indol-3-yl)-1-methyl-ethyl)dimethylamine | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | ? |
| Chemical data | |
| Formula | C13H18N2 |
| Mol. mass | 202.30 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Alpha,N,N-trimethyltryptamine (α,N,N-TMT; α-TMT) is a tryptamine derivative that is a hallucinogenic drug. It is similar in structure to other hallucinogenic tryptamines such as DMT and AMT.
α-TMT has been animal tested in comparison with AMT, and was found to produce similar effects to AMT but is only around half as potent.[1] Anecdotal reports from human users suggest that it produces psychedelic effects similar to those of other tryptamine derivatives when taken orally at a dose of around 80–120 mg, however it does not appear to have been widely sold or used, and its safety profile has not been studied.
 |
This article related to psychedelics, dissociatives and deliriants is a stub. You can help Wikipedia by expanding it. |
[edit] References
- ^ Kalir A, Szara S. Synthesis and pharmacological activity of alkylated tryptamines. Journal of Medicinal Chemistry. 1966 May;9(3):341-4.
|
|||||
